Concepedia

Ivana De Risi

ID

Statistics

Publications

11

Citations

450

H-Index

11

Active since

2019

Affiliations

Istituto Tumori Bari(Current)

Istituti di Ricovero e Cura a Carattere Scientifico

University of Bari Aldo Moro

Istituto Oncologico Veneto

University of Siena

Ivana De Risi is an author at Istituto Tumori Bari specializing in dermatology, radiation oncology, and medicine.

ORCID

Top concepts

Publications per year

2019–2023

11

Publications

11

Circulating extracellular vesicles expressing PD1 and PD-L1 predict response and mediate resistance to checkpoint inhibitors immunotherapy in metastatic melanoma

Simona Serratì, Michele Guida, R. Fonte et al. · Molecular Cancer · 2022 · 142 citations · Full text

Basal and one-month differed neutrophil, lymphocyte and platelet values and their ratios strongly predict the efficacy of checkpoint inhibitors immunotherapy in patients with advanced BRAF wild-type melanoma

Michele Guida, Nicola Bartolomeo, Davide Quaresmini et al. · Journal of Translational Medicine · 2022 · 65 citations · Full text

uPAR<sup>+</sup> extracellular vesicles: a robust biomarker of resistance to checkpoint inhibitor immunotherapy in metastatic melanoma patients

Letizia Porcelli, Michele Guida, Simona De Summa et al. · Journal for ImmunoTherapy of Cancer · 2021 · 43 citations · Full text

Cemiplimab in an Elderly Frail Population of Patients With Locally Advanced or Metastatic Cutaneous Squamous Cell Carcinoma: A Single-Center Real-Life Experience From Italy

Sabino Strippoli, Annarita Fanizzi, Davide Quaresmini et al. · Frontiers in Oncology · 2021 · 40 citations · Full text

No Impact of NRAS Mutation on Features of Primary and Metastatic Melanoma or on Outcomes of Checkpoint Inhibitor Immunotherapy: An Italian Melanoma Intergroup (IMI) Study

Michele Guida, Nicola Bartolomeo, Pietro Quaglino et al. · Cancers · 2021 · 29 citations · Full text

1–5 of 11